LEAH Labs
LEAH Labs, based in Rochester, MN, specializes in developing CAR-T cell therapy for pets with cancer, leveraging a technique approved for human use to treat B cell lymphoma in dogs.
Company Overview of LEAH Labs
LEAH Labs, formerly known as Lifengine Animal Health Laboratories, is headquartered in Rochester, MN, USA. As a small team of three, the company is pioneering new frontiers in the healthcare industry, specifically in the sub-sector of therapeutics. A notable alumnus of the Y Combinator W19 batch, LEAH Labs is focusing on developing innovative cancer treatments for pets.
Advanced Cancer Treatment for Pets
LEAH Labs is at the forefront of developing CAR-T cell therapy for pets with cancer. This treatment, already FDA-approved for human use, involves genetically reprogramming T immune cells to identify and eradicate cancer cells. The company is working on pilot trials for dogs with B cell lymphoma, set to start enrolling in Q1 2024. These trials are available to licensed veterinarians and their patients under specific regulatory guidelines.
Funding and Financial Support
LEAH Labs has received funding from a range of notable investors, including Y Combinator, AgStartup Engine, FIN Capital, Southeast Minnesota Capital, Wefunder, and various angel investors. Additionally, the company has been awarded grants from NSF SBIR, NIH SBIR, LaunchMN, and Regenerative Medicine Minnesota, underscoring their commitment to advancing medical research.
Locations and Market Regions
LEAH Labs operates out of Rochester, MN, USA, and primarily serves the United States and the broader North American region, including Canada. Their innovative treatments are poised to address significant unmet needs in veterinary healthcare across these regions.